This educational initiative is intended for endocrinologists, clinicians, nurse practitioners, and physician assistants caring for individuals with, or at risk for developing hypothyroidism.

Upon successful completion of the webinar, participants should be better able to:

1. Understand key elements for successful telehealth visits
2. Diagnose and/or manage hypothyroidism via telehealth
3. Provide accurate instruction for TSH blood testing at-home
4. Understand telehealth applications useful for people with hypothyroidism

James V. Hennessey, MD – Program Co-Chair
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, MA

J. Woody Sistrunk, MD – Program Co-Chair
Jackson Thyroid & Endocrine Clinic, PLLC
Jackson, Mississippi


Statement of Independence
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this activity.

Disclosure Policy
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

• J. Woody Sistrunk, MD: Research Support, Interpace Diagnostics; Advisory Board Member, Horizon Pharmaceuticals; Speaker, Quidel Diagnostics

The faculty reported the no relevant financial relationship(s) during the content development process for this activity:

• James V. Hennessey, MD

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:

• Howard S. Blank, MD

The following SPC Committee members reported financial relationships:

• Andjela T. Drincic, MD: Advisory Board Member, Corcept

The following SPC members reported no relevant financial relationships:

Beret Ann Casey, MD; Lediya Cheru, MD; Marcelo Correia, MD, PhD; Angela M. Leung, MD; Kelly Lauter Roszko, MD, PhD; Virginia D. Sarapura, MD; Soleymani Taraneh, MD; and Savitha Subramanian, MD

The ES staff involved in the development of this CME activity reported no relevant financial relationships.

Acknowledgement of Commercial Support
This activity is supported by educational grants from AbbVie, Inc.